
The Official @Labroots Cancer Research Page! We are here to discuss the most recent advances in cancer research and therapeutics. Please join our community! 🎗
Joined January 2014
- Tweets5.4K
- Following205
- Followers6.1K
- Likes39
Doctors usually wait for cancer to appear before transplanting bone marrow in patients living with Shwachman-Diamond syndrome, a rare genetic disease.
New data suggest that may be too late.
buff.ly/nlGNFiV
Scientists discover that combination therapy delays recurrent prostate cancer in patients.
buff.ly/MdXx8IP
Researchers incorporate a genetic 'switch' to enhance precision and efficacy in CAR-T cell immunotherapy.
buff.ly/bOK38n3
Scientists discovered a novel mechanism that helps explain why acute myeloid leukemia is so aggressive. This finding can help better inform therapeutic approaches and enhance treatment outcomes.
buff.ly/R6vbXjl
See how 3D spheroid models and live-cell analysis were used to profile 880 FDA-approved compounds, uncovering cytotoxic, cytostatic, and disruptive responses. Learn how 3D assays can deliver richer data and improve in vitro to in vivo translation. buff.ly/qX19AVC
A new study found that less than 40% of Medicaid enrollees with ER+/HER2- breast cancer receive clinically indicated molecular profiling.
buff.ly/n7bgzNH
Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/6xVZBFh
A new study demonstrates a new technique to detect bladder cancer and predict patients who will respond to different treatments.
buff.ly/XbePHGo
Scientists find a way to improve immune cell detection of pediatric brain cancer.
buff.ly/lWBx4ga
Colorectal cancer in young patients can be especially aggressive, with new research finding that nearly all patients in a large pediatric study had advanced-stage disease at diagnosis. buff.ly/9yQwRrZ
🧬🔬 Share your science with the world at Labroots’ 2026 CRISPR Virtual Event Series on October 28, 2026. Submit your poster and gain global visibility!
⏰ Deadline: October 23 at 5:00 pm PT
👉 Submit for free: buff.ly/cAdbeXj
#LRcrispr
Gene‑modified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high‑throughput strategies to characterize CAR T cells—activation, memory, exhaustion, cytokines, and killing. buff.ly/kbahSQo
A new study assesses how financial toxicity correlates with quality of life for patients undergoing treatment for head and neck cancer.
buff.ly/AimJuBf
Understanding what drives sex disparities in cancer incidence could have a significant impact on developing strategies to diagnose and treat cancer.
buff.ly/GGMHFU1
Scientists have developed a non-invasive test to accurately predict bladder cancer.
buff.ly/YGslRso
Missed the live event? No worries. Stream Labroots' 2026 Cancer Research and Oncology Virtual Event on demand and explore expert insights and discoveries advancing cancer research.
🎥 Watch for free: buff.ly/xTYAR0h
#LRcancer
Researchers find a correlation between severe pneumonia and cancer. This discovery could help diagnose blood cancers earlier than before.
buff.ly/ywuIcIy
Learn how 3D assays can deliver richer data and improve in vitro to in vivo translation: buff.ly/eAfwkoQ
A new laser-based technique detects the colorectal cancer biomarker CEACAM-5 in blood plasma within minutes, offering much faster results than conventional methods. buff.ly/wUkEBh3
📚 Free CE credits available! Learn how germline genetic variants may predict CAR T-cell toxicity & expansion, with findings from the ZUMA-1 & ZUMA-7 trials.
📅 Oct 8 | 7 AM PT / 10 AM ET
👉 Register:
buff.ly/nPendPH



